ESI vs SOLS: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
SOLS is the larger of the two ($9.56B market cap): the incumbent the market prices for continued execution (18.07x forward earnings). ESI is the smaller challenger ($7.24B), cheaper on forward earnings (13.77x): more room to run, but more to prove. If you believe SOLS earns its premium (18.07x forward earnings, so the market expects more from it), SOLS fits. If you believe in paying less for profit, ESI fits at 13.77x.
ESI vs SOLS: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ESI | SOLS | What it tells you |
|---|---|---|---|
| Market cap | $7.24B | $9.56B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 13.77 | 18.07 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 35.09 | 29.80 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Price vs 52-week range | 25% of range | 37% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.52 | 6.11 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: ESI is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how ESI and SOLS affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ESI and SOLS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ESI and SOLS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Element Solutions (ESI) do?
Element Solutions Inc is a specialty chemicals company providing high-performance specialty chemistries to electronics, automotive, industrial, and energy customers. The company organizes around two main segments. Electronics provides specialty chemistries for printed circuit board manufacturing, semiconductor packaging, and electronics assembly (including the MacDermid Alpha brand, a major supplier to electronics manufacturers globally). Industrial and Specialty provides specialty surface treatment chemistries, oil and gas chemistries, graphics arts chemistries, and various other industrial specialty chemicals.
What does Solstice Advanced Materials (SOLS) do?
Solstice Advanced Materials is a Morris Plains, New Jersey specialty-chemicals company that began trading on Nasdaq on October 30, 2025 after being spun off from Honeywell. It runs two segments: Refrigerants and Applied Solutions (RAS), which sells low-global-warming-potential refrigerants, blowing agents, solvents and aerosol materials into HVAC/R, automotive, appliance and building end markets, and Electronic and Specialty Materials (ESM), which supplies electronic materials, industrial-grade fibers and life-sciences chemicals to semiconductor, defense, pharmaceutical and construction customers. Full-year 2025 net sales were about $3.9 billion with net income of roughly $237 million and adjusted standalone EBITDA near $957 million, a margin around 24.6%.
ESI vs SOLS: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- ESI drivers: Semiconductor advanced packaging; PCB manufacturing chemistries.
- SOLS drivers: Low-GWP refrigerant transition; Electronics and AI-infrastructure exposure.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Cyclical exposure across electronics and industrial end markets, with the Specialties business already showing flat organic volumes (about 1% organic growth in Q3 2026) and falling segment EBITDA. For SOLS, the Element Solutions merger, which would have added substantial debt through a $4.7 billion bridge facility, has been mutually terminated, so the integration risk is gone but so is the growth opportunity the deal was meant to deliver, and investors will watch what management does next with capital.
ESI or SOLS: which should you pick?
If the story you believe is ESI's (Semiconductor advanced packaging), ESI is the more direct way to own it; if it is SOLS's (Low-GWP refrigerant transition), SOLS is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ESI and SOLS guides.
ESI vs SOLS: the full fundamentals
ESI. The gap between a trailing GAAP P/E near 35 and a forward multiple near 14 reflects acquisition and deal costs in reported earnings versus the roughly $2.17 of adjusted EPS analysts expect in 2027. EV/EBITDA sits around 16x, down from about 19x in October as the share price fell. The average target among 12 analysts was about $47.33, and consensus for Q4 2026 is about $0.47 EPS on about $971 million of revenue.
SOLS. SOLS trades at about 30x trailing earnings because GAAP profit still carries spin-off and deal costs, but on analyst estimates of about $3.36 of EPS in 2027 the forward multiple is closer to 18x, and EV/EBITDA is about 13x. Raised 2026 guidance calls for roughly $4.2 billion of net sales and adjusted diluted EPS of about $2.90 to $2.95, in line with the ~$2.93 consensus. The ten analysts covering it carry a strong-buy consensus with an average target near $77.90.
Headline figures (approximate, November 2026): ESI shows revenue (ttm) ~$3.49 billion, revenue growth (q3 2026, yoy) ~52% (13% organic), operating margin ~12%, net income (ttm) ~$205 million; SOLS shows market cap ~$9.6B, revenue (ttm) ~$4.17B; Q3 2026 ~$1.05B, up ~8% YoY, net income (ttm) ~$324M, margins (ttm) gross ~31%, operating ~17%, net ~8%.
The bottom line: ESI vs SOLS
ESI and SOLS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ESI and SOLS exposure against your real portfolio. It is not an investment adviser.
Wondering how ESI or SOLS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Element Solutions
Ask Walnut's AI anything about ESI and see how it fits what you own.
FAQ
What is the difference between ESI and SOLS?
+
Element Solutions Inc is a specialty chemicals company providing high-performance specialty chemistries to electronics, automotive, industrial, and energy customers. Solstice Advanced Materials is a Morris Plains, New Jersey specialty-chemicals company that began trading on Nasdaq on October 30, 2025 after being spun off from Honeywell. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ESI or SOLS the better stock?
+
Neither is universally better. SOLS is the larger incumbent; ESI is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ESI or SOLS?
+
On forward P/E (as of November 2026), ESI trades at 13.77x and SOLS at 18.07x, so ESI is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ESI and SOLS?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ESI vs SOLS?
+
ESI: Cyclical exposure across electronics and industrial end markets, with the Specialties business already showing flat organic volumes (about 1% organic growth in Q3 2026) and falling segment EBITDA. Customer concentration in major electronics manufacturers, and a heavier reliance on AI-related semiconductor demand that could cool. Integration risk from the Micromax and EFC acquisitions, plus leverage of about $2.1 billion of debt. GAAP profitability is thin relative to the adjusted figures (trailing net margin about 5.9%, trailing P/E near 35), and free cash flow over the trailing twelve months was only about $114 million, though Q3 alone produced about $134.5 million. The terminated Solstice deal removed a takeout price near $50 per share, and the shares have fallen about 16% over three months to about $29.86 even as results beat; analyst targets have been trimmed (Mizuho to $42 from $45 in October 2026). Pass-through of raw material cost inflation can lag during volatile periods. SOLS: The Element Solutions merger, which would have added substantial debt through a $4.7 billion bridge facility, has been mutually terminated, so the integration risk is gone but so is the growth opportunity the deal was meant to deliver, and investors will watch what management does next with capital. The stock trades at about 30x trailing earnings in November 2026, against roughly 18x forward, so any earnings disappointment could weigh on it, and the shares fell on the day of the Q3 beat. Debt of about $2.4 billion is roughly 1.5 times equity. Legacy liabilities matter too: the company has reached only an agreement in principle to settle litigation over the Metropolis Works uranium conversion plant, and that deal still needs formal documentation and approvals. Refrigerant markets are cyclical and exposed to feedstock costs, regulatory shifts and competition from larger chemical players. The electronics and semiconductor end markets are also cyclical, and as a recently spun-off company SOLS has a short standalone trading history, with a 52-week range of about $43 to $91.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ESI or SOLS; figures are approximate and dated (as of November 2026). Verify current data before investing.